1. Home
  2. ELDN vs FTF Comparison

ELDN vs FTF Comparison

Compare ELDN & FTF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eledon Pharmaceuticals Inc.

ELDN

Eledon Pharmaceuticals Inc.

HOLD

Current Price

$3.10

Market Cap

235.1M

Sector

Health Care

ML Signal

HOLD

Logo Franklin Limited Duration Income Trust of Beneficial Interest

FTF

Franklin Limited Duration Income Trust of Beneficial Interest

HOLD

Current Price

$5.92

Market Cap

240.8M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
ELDN
FTF
Founded
2004
N/A
Country
United States
United States
Employees
33
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Finance/Investors Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
235.1M
240.8M
IPO Year
2014
2003

Fundamental Metrics

Financial Performance
Metric
ELDN
FTF
Price
$3.10
$5.92
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$8.50
N/A
AVG Volume (30 Days)
1.3M
173.5K
Earning Date
05-13-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
30.67
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.35
$5.70
52 Week High
$4.60
$6.54

Technical Indicators

Market Signals
Indicator
ELDN
FTF
Relative Strength Index (RSI) 59.62 51.60
Support Level $2.45 $5.86
Resistance Level $3.17 $6.19
Average True Range (ATR) 0.20 0.08
MACD -0.01 0.02
Stochastic Oscillator 70.00 83.69

Price Performance

Historical Comparison
ELDN
FTF

About ELDN Eledon Pharmaceuticals Inc.

Eledon Pharmaceuticals Inc is a clinical stage biotechnology company using immunology expertise in targeting the CD40 Ligand pathway to develop therapies to protect transplanted organs and prevent rejection, and to treat amyotrophic lateral sclerosis. Its compound in development is tegoprubart, an IgG1, anti-CD40L antibody with high affinity for the CD40L, a well-validated biological target that has broad therapeutic potential. It operates as one reportable segment, focused on the development of tegoprubart, to develop therapies to protect transplanted organs and prevent rejection, and to treat ALS.

About FTF Franklin Limited Duration Income Trust of Beneficial Interest

Franklin Limited Duration Income Trust is a closed-end investment company based in the United States. It conducts its investment to provide high, current income, with a secondary objective of capital appreciation. To align with its investment objective, is to invest in a diversified mix of fixed-income securities. Its portfolio is dominated by considerable investments in high-yield corporate bonds while touching upon other avenues such as senior secured floating rate corporate loans, mortgage-backed securities, commercial mortgage-backed securities, asset-backed securities, common stocks, and other short-term investments.

Share on Social Networks: